I was in too much pain for anything good to happen
Monitor levels every 6 months given high-risk status
The tirzepatide to semaglutide switching guide provides relevant context for the GLP-1 component transition
This includes appropriate personal protective equipment, clean preparation surfaces, labelled containers, controlled disposal, and accurate record keeping
Aroda, M.D., from Brigham and Women's Hospital in Boston, and colleagues randomly assigned adults with type 2 diabetes inadequately controlled with diet and exercise to receive once-weekly subcutaneous cagrilintide 2.4 mg plus semaglutide 2.4 mg, cagrilintide 1.0 mg plus semaglutide 1.0 mg, or placebo for 40 weeks (62, 63, and 64 participants, respectively)